This article was originally published in The Gray Sheet
CMS announces Nov. 23 its decision to withdraw Medicare coverage for certain 2-[F-18] fluoro-D-glucose PET scanners. As of Jan. 1, PET imaging must be performed on either FDA-approved full or partial-ring scanners or coincidence systems that have a crystal at least 5/8" thick, techniques to minimize or correct for scatter and or randoms, and digital detectors and iterative reconstruction. The reduction in coverage was originally proposed in a June 29 decision memorandum (1"The Gray Sheet" July 9, 2001, p. 4)...
You may also be interested in...
Gamma cameras must have a crystal thickness of at least 5/8 inches to continue receiving Medicare reimbursement for PET indications covered prior to December 2000, the Centers for Medicare & Medicaid Services (formerly HCFA) states in a June 29 decision.
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.